Court Addresses What a Lay Corporate Witness Designee Do to Prepare for a 30(b)(6) Deposition in a Patent and Admonishes Parties to Cooperate in Discovery or Sanctions Will Be Assessed
Plaintiff Bayer Healthcare Pharmaceuticals, Inc. (“Bayer”) and Dow Pharmaceutical Sciences, Inc. (“Dow”) (collectively “plaintiffs”) sought specific relief after an emergency status conference had been held at their request. The relief sought included (1) an extension of the statutory 30-month stay based on defendants’ discovery cooperation failure; (2) to […]